IVA · Inventiva ADR
United States · RS rating 41 · As of 2026-11-03
| Price | 4.03 USD |
|---|---|
| 1-day change | +5.2% |
| RS rating (overall / 1M / 3M / 12M) | 41 / 90 / 38 / 46 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 28 / 18 / 14 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +43.6% |
| Market cap (USD) | $1.1B |